New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
14:32 EDTPHGPhilips receives FDA clearance to market MicroDose SI mammography system
Royal Philips Electronics announces 510(k) clearance from the FDA for its MicroDose SI system, the first full-field digital mammography system on the market with the capability to enable future Single-Shot Spectral Imaging applications. Philips is working on future software applications like Spectral Breast Density Measurement, which will build upon the MicroDose SI technology.
News For PHG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2015
10:48 EDTPHGNuance rises after earnings as analysts point to bookings as positive sign
Shares of Nuance Communications (NUAN) climbed in morning trading after analysts from Deutsche Bank and Oppenheimer raised their price targets on the company following upbeat fourth quarter earnings. WHAT'S NEW: After the market close yesterday, Nuance reported Q4 earnings per share of 41c, beating analyst estimates of 35c, on revenue of $504.1M, just short of consensus $507.84M. The company provided guidance for fiscal 2016, saying it expects earnings per share for the year in the range of $1.35-$1.45 on revenue of $1.95B-$2B. Nuance also said it expects first quarter EPS of 31c-33c on revenue of $477.8M-$489.8M. WHAT'S NOTABLE: In the same press release, Nuance chief financial officer Dan Tempesta said that the company has made "substantial progress" on its company-wide transformation project. "We expect to continue our improvements in financial performance and lead the company to improved growth in 2016 and beyond," Tempesta said. STREET RESEARCH: Following the quarterly report, Deutsche Bank analyst Nandan Amladi maintained a Buy rating on the company's stock and raised its price target to $30 from $25, citing greater visibility from recurring revenue. Amladi said that Nuance had a "robust" finish to fiscal 2015 and that bookings and recurring revenue metrics were stronger than traditional licenses. The analyst added that the company's outlook leaves some headroom for upside and that its buyback activity should continue its "pronounced" pace heading into FY16. In addition, Oppenheimer analyst Shaul Eyal maintained an Outperform rating on Nuance and raised the price target on the company's shares to $26 from $22, saying that the company's shift towards a more software-as-a-service focused business model shows positive indications. Eyal added that the company's fundamentals are improving and that EPS accretion is supported by an ongoing share repurchase and cost containment measures. PRICE ACTION: In morning trading, Nuance rallied 14.5% to $19.53. OTHERS TO WATCH: Philips (PHG), which reached a collaboration agreement with Nuance a month ago to provide Nuance users its PowerScribe 360 software, was up 1.4% in morning trading.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use